{"protocolSection": {"identificationModule": {"nctId": "NCT00748579", "orgStudyIdInfo": {"id": "CY 1124"}, "organization": {"fullName": "Cytokinetics", "class": "INDUSTRY"}, "briefTitle": "Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency", "officialTitle": "A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction"}, "statusModule": {"statusVerifiedDate": "2020-01", "overallStatus": "TERMINATED", "whyStopped": "Decision to discontinue due to challenges of trial design and constraints on enrolling eligible and consenting patients.", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-09"}, "primaryCompletionDateStruct": {"date": "2008-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2009-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-04-21", "studyFirstSubmitQcDate": "2008-09-04", "studyFirstPostDateStruct": {"date": "2008-09-08", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2010-07-30", "resultsFirstSubmitQcDate": "2010-07-30", "resultsFirstPostDateStruct": {"date": "2010-08-23", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2020-01-10", "lastUpdatePostDateStruct": {"date": "2020-01-21", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Cytokinetics", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose for this study (CY 1124) is to evaluate the effects of CK-1827452, a cardiac myosin activator, on myocardial systolic performance, myocardial oxygen consumption, and myocardial efficiency in patients with heart failure and to confirm that the unique preclinical pharmacological profile of CK- 1827452 is substantially the same in patients with heart failure."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 2, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Cohort 1", "type": "EXPERIMENTAL", "description": "0.5 hour loading dose followed by 1.0 hour maintenance dose of CK-1827452", "interventionNames": ["Drug: CK-1827452"]}, {"label": "Cohort 2", "type": "EXPERIMENTAL", "description": "\u2264 1.0 hour loading dose followed by 1.0 hour maintenance dose of CK-1827452", "interventionNames": ["Drug: CK-1827452"]}], "interventions": [{"type": "DRUG", "name": "CK-1827452", "description": "I.V. infusion for 0.5 hour at 54mg/hr followed by 1 hour at 21mg/hr", "armGroupLabels": ["Cohort 1"]}, {"type": "DRUG", "name": "CK-1827452", "description": "I.V. infusion for \u2264 1 hour at 72mg/hr followed by 1 hour at 36mg/hr", "armGroupLabels": ["Cohort 2"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Effect of CK-1827452 on Myocardial Efficiency, Defined as the Ratio of Ventricular Performance to Myocardial Oxygen Consumption.", "description": "Measure the effect CK-1827452 on hemodynamics and energetic measures of ventricular performance, myocardial oxygen consumption, and myocardial efficiency (the ratio of ventricular performance to myocardial oxygen consumption), in patients with clinical heart failure.", "timeFrame": "1 day"}], "secondaryOutcomes": [{"measure": "Effects of CK-1827452 on Ventricular Performance", "description": "Measure the effect of CK-1824752 on ventricular performance", "timeFrame": "1 day"}, {"measure": "Effects of CK-1827452 on Myocardial Oxygen Consumption", "description": "Measure the effect of CK-1824752 on myocardial oxygen consumption", "timeFrame": "1 day"}, {"measure": "Effects of CK-1827452 on Pressure-volume Relationships", "description": "Measure the effect of CK-1824752 on pressure-volume relationships", "timeFrame": "1 day"}, {"measure": "Effects of CK-1827452 on Systolic Ejection Time", "description": "Measure the effect of CK-1824752 on systolic ejection time", "timeFrame": "1 day"}, {"measure": "Effects of CK-1827452 on Invasively Measured Hemodynamics, Including Filling Pressure and Cardiac Output", "description": "Measure the effect of CK-1824752 on invasively measured hemodynamics, including filling pressure and cardiac output", "timeFrame": "1 day"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical indication for left and right heart catheterization\n* Willing and able to provide informed consent\n* Male or female 18 years of age or greater\n* Symptomatic heart failure (\u2265 NYHA Class II)\n* Ejection fraction \u2264 35%\n* Patient is in sinus rhythm\n* Patient is considered to be in suitable health in the opinion of the investigator, as determined by:\n\n  o A pre-study physical examination with no clinical abnormalities which in the opinion of the investigator would preclude participation in the study other than physical symptoms or signs consistent with stable heart failure\n* For female patients only: Post-menopausal or sterilized, or if she is of childbearing potential, she is not breastfeeding, her pregnancy test is negative, she has no intention to become pregnant for up to 90 days following the study, and she is using contraceptive drugs or devices\n\nExclusion Criteria:\n\n* Acute myocarditis\n* Hypertrophic, restrictive, or constrictive cardiomyopathy\n* Congenital heart disease\n* Known left ventricular thrombus\n* Significant stenotic valvular disease (severe aortic stenosis, mitral stenosis)\n* Poorly controlled hypertension (SBP \\> 180 mmHg)\n* Pacemaker dependent ventricular rhythm\n* Detectable troponin or CK-MB \\> ULN at any timepoint within 14 days of enrollment\n* Acute coronary syndrome or revascularization procedure within 30 days of enrollment\n* \u2265 50% stenosis of the left main coronary artery\n* Plan for immediate revascularization procedure (PCI or CABG)\n* GFR \u2264 35 ml/min/1.73 m2 by Modification of Diet in Renal Disease (MDRD) Equation or need for renal replacement therapy\n* Known hepatic impairment (total bilirubin \\> 3 mg/dL, or ALT and AST \\> 2 times the upper limit of normal)\n* Has received an investigational drug or device within 30 days before enrollment\n* Has had any prior treatment with CK-1827452", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Johns Hopkins Medical Institutions", "city": "Baltimore", "state": "Maryland", "zip": "21205", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "UUHSC / Division of Cardiology", "city": "Salt Lake City", "state": "Utah", "zip": "84132", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "Mount Sinai Hospital", "city": "Toronto", "state": "Ontario", "zip": "M5G 1X5", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "The recruitment period was from September 2008 to July 2009.", "groups": [{"id": "FG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "FG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Study was terminated due to challenges of trial design and constraints on enrolling eligible and consenting patients", "groups": [{"id": "BG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "BG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG002", "value": "1"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "69", "spread": "13"}, {"groupId": "BG002", "value": "69", "spread": "13"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG002", "value": "2"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG002", "value": "2"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Effect of CK-1827452 on Myocardial Efficiency, Defined as the Ratio of Ventricular Performance to Myocardial Oxygen Consumption.", "description": "Measure the effect CK-1827452 on hemodynamics and energetic measures of ventricular performance, myocardial oxygen consumption, and myocardial efficiency (the ratio of ventricular performance to myocardial oxygen consumption), in patients with clinical heart failure.", "populationDescription": "Study was terminated due to poor enrollment; 2 participants completed the study. Data quantity was insufficient to analyze or draw conclusions.", "reportingStatus": "POSTED", "timeFrame": "1 day", "groups": [{"id": "OG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "OG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Effects of CK-1827452 on Ventricular Performance", "description": "Measure the effect of CK-1824752 on ventricular performance", "populationDescription": "No data displayed because Outcome Measure has zero total participants analyzed.", "reportingStatus": "POSTED", "timeFrame": "1 day", "groups": [{"id": "OG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "OG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Effects of CK-1827452 on Myocardial Oxygen Consumption", "description": "Measure the effect of CK-1824752 on myocardial oxygen consumption", "populationDescription": "No data displayed because Outcome Measure has zero total participants analyzed.", "reportingStatus": "POSTED", "timeFrame": "1 day", "groups": [{"id": "OG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "OG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Effects of CK-1827452 on Pressure-volume Relationships", "description": "Measure the effect of CK-1824752 on pressure-volume relationships", "populationDescription": "No data displayed because Outcome Measure has zero total participants analyzed.", "reportingStatus": "POSTED", "timeFrame": "1 day", "groups": [{"id": "OG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "OG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Effects of CK-1827452 on Systolic Ejection Time", "description": "Measure the effect of CK-1824752 on systolic ejection time", "populationDescription": "No data displayed because Outcome Measure has zero total participants analyzed.", "reportingStatus": "POSTED", "timeFrame": "1 day", "groups": [{"id": "OG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "OG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Effects of CK-1827452 on Invasively Measured Hemodynamics, Including Filling Pressure and Cardiac Output", "description": "Measure the effect of CK-1824752 on invasively measured hemodynamics, including filling pressure and cardiac output", "populationDescription": "No data displayed because Outcome Measure has zero total participants analyzed.", "reportingStatus": "POSTED", "timeFrame": "1 day", "groups": [{"id": "OG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}, {"id": "OG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "30 days", "description": "T", "eventGroups": [{"id": "EG000", "title": "Mid Dose CK-1827452 (Cohort 1)", "description": "0.5 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452", "seriousNumAffected": 0, "seriousNumAtRisk": 2, "otherNumAffected": 2, "otherNumAtRisk": 2}, {"id": "EG001", "title": "High Dose CK-1827452 (Cohort 2)", "description": "\u2264 1.0 hour loading infusion followed by 1.0 hour maintenance infusion of CK-1827452", "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 0, "otherNumAtRisk": 0}], "otherEvents": [{"term": "Troponin Increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "The 2 troponin increases were mild in intensity and resolved.", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 2}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}, {"term": "Supraventricular Tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 11.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "The 1 supraventricular tachycardia was mild in intensity and resolved.", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 2}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 0}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Inadequate enrollment led to early termination of study and insufficient number of patients for analysis."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Sponsor's intention was to publish the results of the trial in collaboration with the Investigators."}, "pointOfContact": {"title": "Medical Director", "organization": "Cytokinetics, Inc.", "phone": "(650) 624-3011"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M27583", "name": "Systolic Murmurs", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}}, "hasResults": true}